Harrow, Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Harrow, Inc. and other ETFs, options, and stocks.About HROW
Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development.
CEOMark L. Baum
CEOMark L. Baum
Employees382
Employees382
HeadquartersNashville, Tennessee
HeadquartersNashville, Tennessee
Founded2006
Founded2006
Employees382
Employees382
HROW Key Statistics
Market cap1.32B
Market cap1.32B
Price-Earnings ratio-59.55
Price-Earnings ratio-59.55
Dividend yield—
Dividend yield—
Average volume471.65K
Average volume471.65K
High today$37.20
High today$37.20
Low today$35.60
Low today$35.60
Open price$36.13
Open price$36.13
Volume481.96K
Volume481.96K
52 Week high$59.23
52 Week high$59.23
52 Week low$20.85
52 Week low$20.85
HROW News
TipRanks 1d
Harrow Health’s Strategic Acquisition and Market Positioning Justify Buy RatingWilliam Blair analyst Lachlan Hanbury Brown has maintained their bullish stance on HROW stock, giving a Buy rating today. Elevate Your Investing Strategy: Tak...
Analyst ratings
100%
of 8 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own HROW. This list is generated using Robinhood data, and it’s not a recommendation.